Acumen Pharmaceuticals (ABOS) Net Cash Flow (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Acumen Pharmaceuticals | 164.37 Mn | 35.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -130.65% |
| Dec 31, 2025 | -28.60% |
| Sep 30, 2025 | 50.68% |
| Jun 30, 2025 | 221.63% |
| Mar 31, 2025 | -324.19% |
| Dec 31, 2024 | 107.01% |
| Sep 30, 2024 | -265.37% |
| Jun 30, 2024 | 205.37% |
| Mar 31, 2024 | 28.70% |
| Dec 31, 2023 | -256.72% |
| Sep 30, 2023 | 2,477.90% |
| Jun 30, 2023 | 98.56% |
| Mar 31, 2023 | -89.88% |
| Dec 31, 2022 | -159.04% |
| Sep 30, 2022 | 1,905.74% |
| Jun 30, 2022 | 117.29% |
| Mar 31, 2022 | 1.77% |
| Dec 31, 2021 | -120.36% |
| Sep 30, 2021 | 1,671.06% |
| Jun 30, 2021 | -79.92% |
| Mar 31, 2021 | 17.05% |
| Dec 31, 2020 | -122.68% |